PHARMACOKINETICS OF PROPRANOLOL AND SOTALOL IN HYPERTHYROIDISM

被引：19

作者：

ARO, A ^{[1
]}

ANTTILA, M ^{[1
]}

KORHONEN, T ^{[1
]}

SUNDQUIST, H ^{[1
]}

机构：

[1] FARMOS GRP LTD,RES CTR,TURKU,FINLAND

来源：

关键词：

D O I：

10.1007/BF00542321

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：373 / 377

页数：5

共 34 条

[1] [Anonymous], 1980, LANCET, V1, P184
[2] ANTTILA M, 1976, ACTA PHARMACOL TOX, V39, P118
[3] COMPARISON OF PROPRANOLOL AND CARBIMAZOLE AS ADJUNCTS TO I-131 THERAPY OF HYPERTHYRODISM
ARO, A
HUTTUNEN, JK
LAMBERG, BA
PELKONEN, R
IKKALA, E
KUUSISTO, A
RISSANEN, V
SALMI, J
TERVONEN, S
[J]. ACTA ENDOCRINOLOGICA, 1981, 96 (03): : 321 - 327
[4] EFFECT OF BETA-BLOCKERS ON THYROID-HORMONE
BAX, NDS
LENNARD, MS
TUCKER, GT
[J]. BRITISH MEDICAL JOURNAL, 1980, 281 (6250) : 1283 - 1283
[5] STUDIES OF EFFECT OF THYROID DYSFUNCTION ON ELIMINATION OF BETA-ADRENOCEPTOR BLOCKING-DRUGS
BELL, JM
RUSSELL, CJ
NELSON, JK
KELLY, JG
MCDEVITT, DG
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (01) : 79 - 82
[6] THYROID AND KIDNEY
BRADLEY, SE
STEPHAN, F
COELHO, JB
REVILLE, P
[J]. KIDNEY INTERNATIONAL, 1974, 6 (05) : 346 - 365
[7] EICHELBAUM M, 1976, Clinical Pharmacokinetics, V1, P339, DOI 10.2165/00003088-197601050-00002
[8] PROPRANOLOL DOES NOT PREVENT THYROID STORM
ERIKSSON, M
RUBENFELD, S
GARBER, AJ
KOHLER, PO
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (05) : 263 - 264
[9] FEELY J, 1977, BRIT MED J, V2, P1352
[10] PROPRANOLOL, TRIIODOTHYRONINE, REVERSE TRIIODOTHYRONINE AND THYROID-DISEASE
FEELY, J
ISLES, TE
RATCLIFFE, WA
CROOKS, J
[J]. CLINICAL ENDOCRINOLOGY, 1979, 10 (05) : 531 - 538